These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17245558)

  • 1. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study.
    Leuzzi V; Tosetti M; Montanaro D; Carducci C; Artiola C; Carducci C; Antonozzi I; Burroni M; Carnevale F; Chiarotti F; Popolizio T; Giannatempo GM; D'Alesio V; Scarabino T
    J Inherit Metab Dis; 2007 Apr; 30(2):209-16. PubMed ID: 17245558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
    J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion.
    Scarabino T; Popolizio T; Tosetti M; Montanaro D; Giannatempo GM; Terlizzi R; Pollice S; Maiorana A; Maggialetti N; Carriero A; Leuzzi V; Salvolini U
    Radiol Med; 2009 Apr; 114(3):461-74. PubMed ID: 19277839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging.
    Vermathen P; Robert-Tissot L; Pietz J; Lutz T; Boesch C; Kreis R
    Magn Reson Med; 2007 Dec; 58(6):1145-56. PubMed ID: 18046700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of brain maturation in the preterm infants using diffusion tensor imaging (DTI) and enhanced T2 star weighted angiography (ESWAN).
    Ling X; Tang W; Liu G; Huang L; Li B; Li X; Liu S; Xu J
    Eur J Radiol; 2013 Sep; 82(9):e476-83. PubMed ID: 23639775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.
    Pietz J; Meyding-Lamadé UK; Schmidt H
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria.
    Rupp A; Kreis R; Zschocke J; Slotboom J; Boesch C; Rating D; Pietz J
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):276-84. PubMed ID: 11295882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria.
    Manara R; Burlina AP; Citton V; Ermani M; Vespignani F; Carollo C; Burlina AB
    Neuroradiology; 2009 Dec; 51(12):803-12. PubMed ID: 19652961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral blood flow and white matter alterations in adults with phenylketonuria.
    Steiner L; Muri R; Wijesinghe D; Jann K; Maissen-Abgottspon S; Radojewski P; Pospieszny K; Kreis R; Kiefer C; Hochuli M; Trepp R; Everts R
    Neuroimage Clin; 2024; 41():103550. PubMed ID: 38091797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of diffusion tensor imaging in the evaluation of ischemic brain injury - a review.
    Sotak CH
    NMR Biomed; 2002; 15(7-8):561-9. PubMed ID: 12489102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.
    Leuzzi V; Trasimeni G; Gualdi GF; Antonozzi I
    J Inherit Metab Dis; 1995; 18(5):624-34. PubMed ID: 8598645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.
    Phillips MD; McGraw P; Lowe MJ; Mathews VP; Hainline BE
    AJNR Am J Neuroradiol; 2001 Sep; 22(8):1583-6. PubMed ID: 11559511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
    Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
    Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. True Restriction in Diffusion-Weighted Imaging in a Mistreated Patient With Phenylketonuria.
    Palaiodimou L; Zompola C; Lachanis S; Mylona V; Theodorou A; Papagiannopoulou G; Kotsali-Peteinelli V; Foska A; Kasti A; Skouma A; Tsivgoulis G
    Neurologist; 2020 Dec; 26(1):20-21. PubMed ID: 33394907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter- and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU).
    Clocksin HE; Hawks ZW; White DA; Christ SE
    Mol Genet Metab; 2021 Jan; 132(1):11-18. PubMed ID: 33334682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria.
    Hood A; Antenor-Dorsey JA; Rutlin J; Hershey T; Shimony JS; McKinstry RC; Grange DK; Christ SE; Steiner R; White DA
    Mol Genet Metab; 2015 Jan; 114(1):19-24. PubMed ID: 25481106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.